Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1994 Nov 1;180(5):1861–1871. doi: 10.1084/jem.180.5.1861

Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains

PMCID: PMC2191747  PMID: 7525842

Abstract

The CD58 binding site on human CD2 was recently shown by nuclear magnetic resonance structural data in conjunction with site-directed mutagenesis to be a highly charged surface area covering approximately 770A2 on the major AGFCC'C" face of the CD2 immunoglobulin-like (Ig- like) NH2-terminal domain. Here we have identified the other binding surface of the CD2-CD58 adhesion pair by mutating charged residues shared among CD2 ligands (human CD58, sheep CD58, and human CD48) that are predicted to be solvent exposed on a molecular model of the Ig-like adhesion domain of human CD58. This site includes beta strand residues along the C strand (E25, K29, and K30), in the middle of the C' strand (E37) and in the G strand (K87). In addition, several residues on the CC' loop (K32, D33, and K34) form this site. Thus, the interaction between CD2 and CD58 involves the major beta sheet surface of each adhesion domain. Possible docking orientations for the CD2-CD58 molecular complex are offered. Strict conservation of human and sheep CD58 residues within the involved C and C' strands and CC' loop suggests that this region is particularly important for stable formation of the CD2-CD58 complex. The analysis of this complex offers molecular insight into the nature of a receptor-ligand pair involving two Ig family members.

Full Text

The Full Text of this article is available as a PDF (4.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arulanandam A. R., Koyasu S., Reinherz E. L. T cell receptor-independent CD2 signal transduction in FcR+ cells. J Exp Med. 1991 Apr 1;173(4):859–868. doi: 10.1084/jem.173.4.859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arulanandam A. R., Moingeon P., Concino M. F., Recny M. A., Kato K., Yagita H., Koyasu S., Reinherz E. L. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J Exp Med. 1993 May 1;177(5):1439–1450. doi: 10.1084/jem.177.5.1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arulanandam A. R., Withka J. M., Wyss D. F., Wagner G., Kister A., Pallai P., Recny M. A., Reinherz E. L. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11613–11617. doi: 10.1073/pnas.90.24.11613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ban N., Escobar C., Garcia R., Hasel K., Day J., Greenwood A., McPherson A. Crystal structure of an idiotype-anti-idiotype Fab complex. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1604–1608. doi: 10.1073/pnas.91.5.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bentley G. A., Boulot G., Riottot M. M., Poljak R. J. Three-dimensional structure of an idiotope-anti-idiotope complex. Nature. 1990 Nov 15;348(6298):254–257. doi: 10.1038/348254a0. [DOI] [PubMed] [Google Scholar]
  6. Bierer B. E., Peterson A., Gorga J. C., Herrmann S. H., Burakoff S. J. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med. 1988 Sep 1;168(3):1145–1156. doi: 10.1084/jem.168.3.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bierer B. E., Sleckman B. P., Ratnofsky S. E., Burakoff S. J. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol. 1989;7:579–599. doi: 10.1146/annurev.iy.07.040189.003051. [DOI] [PubMed] [Google Scholar]
  8. Brain P., Gordon J., Willetts W. A. Rosette formation by peripheral lymphocytes. Clin Exp Immunol. 1970 May;6(5):681–688. [PMC free article] [PubMed] [Google Scholar]
  9. Chang H. C., Moingeon P., Lopez P., Krasnow H., Stebbins C., Reinherz E. L. Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production. J Exp Med. 1989 Jun 1;169(6):2073–2083. doi: 10.1084/jem.169.6.2073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chothia C., Novotný J., Bruccoleri R., Karplus M. Domain association in immunoglobulin molecules. The packing of variable domains. J Mol Biol. 1985 Dec 5;186(3):651–663. doi: 10.1016/0022-2836(85)90137-8. [DOI] [PubMed] [Google Scholar]
  11. Colman P. M. Structure of antibody-antigen complexes: implications for immune recognition. Adv Immunol. 1988;43:99–132. doi: 10.1016/s0065-2776(08)60364-8. [DOI] [PubMed] [Google Scholar]
  12. Coombs R. R., Gurner B. W., Wilson A. B., Holm G., Lindgren B. Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors. Int Arch Allergy Appl Immunol. 1970;39(5-6):658–663. doi: 10.1159/000230390. [DOI] [PubMed] [Google Scholar]
  13. Dengler T. J., Hoffmann J. C., Knolle P., Albert-Wolf M., Roux M., Wallich R., Meuer S. C. Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3). Eur J Immunol. 1992 Nov;22(11):2809–2817. doi: 10.1002/eji.1830221109. [DOI] [PubMed] [Google Scholar]
  14. Diamond D. J., Clayton L. K., Sayre P. H., Reinherz E. L. Exon-intron organization and sequence comparison of human and murine T11 (CD2) genes. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1615–1619. doi: 10.1073/pnas.85.5.1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Driscoll P. C., Cyster J. G., Campbell I. D., Williams A. F. Structure of domain 1 of rat T lymphocyte CD2 antigen. Nature. 1991 Oct 24;353(6346):762–765. doi: 10.1038/353762a0. [DOI] [PubMed] [Google Scholar]
  16. Epp O., Lattman E. E., Schiffer M., Huber R., Palm W. The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. Biochemistry. 1975 Nov 4;14(22):4943–4952. doi: 10.1021/bi00693a025. [DOI] [PubMed] [Google Scholar]
  17. Gray F., Cyster J. G., Willis A. C., Barclay A. N., Williams A. F. Structural analysis of the CD2 T lymphocyte antigen by site-directed mutagenesis to introduce a disulphide bond into domain 1. Protein Eng. 1993 Nov;6(8):965–970. doi: 10.1093/protein/6.8.965. [DOI] [PubMed] [Google Scholar]
  18. He Q., Beyers A. D., Barclay A. N., Williams A. F. A role in transmembrane signaling for the cytoplasmic domain of the CD2 T lymphocyte surface antigen. Cell. 1988 Sep 23;54(7):979–984. doi: 10.1016/0092-8674(88)90112-2. [DOI] [PubMed] [Google Scholar]
  19. Hünig T., Tiefenthaler G., Meyer zum Büschenfelde K. H., Meuer S. C. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand. Nature. 1987 Mar 19;326(6110):298–301. doi: 10.1038/326298a0. [DOI] [PubMed] [Google Scholar]
  20. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jones E. Y., Davis S. J., Williams A. F., Harlos K., Stuart D. I. Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. Nature. 1992 Nov 19;360(6401):232–239. doi: 10.1038/360232a0. [DOI] [PubMed] [Google Scholar]
  22. Kato K., Koyanagi M., Okada H., Takanashi T., Wong Y. W., Williams A. F., Okumura K., Yagita H. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med. 1992 Nov 1;176(5):1241–1249. doi: 10.1084/jem.176.5.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Koyasu S., Lawton T., Novick D., Recny M. A., Siliciano R. F., Wallner B. P., Reinherz E. L. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2603–2607. doi: 10.1073/pnas.87.7.2603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Krensky A. M., Sanchez-Madrid F., Robbins E., Nagy J. A., Springer T. A., Burakoff S. J. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol. 1983 Aug;131(2):611–616. [PubMed] [Google Scholar]
  25. Lay W. H., Mendes N. F., Bianco C., Nussenzweig V. Binding of sheep red blood cells to a large population of human lymphocytes. Nature. 1971 Apr 23;230(5295):531–532. doi: 10.1038/230531a0. [DOI] [PubMed] [Google Scholar]
  26. Leahy D. J., Axel R., Hendrickson W. A. Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution. Cell. 1992 Mar 20;68(6):1145–1162. doi: 10.1016/0092-8674(92)90085-q. [DOI] [PubMed] [Google Scholar]
  27. Meuer S. C., Hussey R. E., Fabbi M., Fox D., Acuto O., Fitzgerald K. A., Hodgdon J. C., Protentis J. P., Schlossman S. F., Reinherz E. L. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell. 1984 Apr;36(4):897–906. doi: 10.1016/0092-8674(84)90039-4. [DOI] [PubMed] [Google Scholar]
  28. Miller G. T., Hochman P. S., Meier W., Tizard R., Bixler S. A., Rosa M. D., Wallner B. P. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J Exp Med. 1993 Jul 1;178(1):211–222. doi: 10.1084/jem.178.1.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Moingeon P. E., Lucich J. L., Stebbins C. C., Recny M. A., Wallner B. P., Koyasu S., Reinherz E. L. Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation. Eur J Immunol. 1991 Mar;21(3):605–610. doi: 10.1002/eji.1830210311. [DOI] [PubMed] [Google Scholar]
  30. Moingeon P., Chang H. C., Sayre P. H., Clayton L. K., Alcover A., Gardner P., Reinherz E. L. The structural biology of CD2. Immunol Rev. 1989 Oct;111:111–144. doi: 10.1111/j.1600-065x.1989.tb00544.x. [DOI] [PubMed] [Google Scholar]
  31. Moingeon P., Chang H. C., Wallner B. P., Stebbins C., Frey A. Z., Reinherz E. L. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature. 1989 May 25;339(6222):312–314. doi: 10.1038/339312a0. [DOI] [PubMed] [Google Scholar]
  32. Moingeon P., Lucich J. L., McConkey D. J., Letourneur F., Malissen B., Kochan J., Chang H. C., Rodewald H. R., Reinherz E. L. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1492–1496. doi: 10.1073/pnas.89.4.1492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Peterson A., Seed B. Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2). 1987 Oct 29-Nov 4Nature. 329(6142):842–846. doi: 10.1038/329842a0. [DOI] [PubMed] [Google Scholar]
  34. Recny M. A., Neidhardt E. A., Sayre P. H., Ciardelli T. L., Reinherz E. L. Structural and functional characterization of the CD2 immunoadhesion domain. Evidence for inclusion of CD2 in an alpha-beta protein folding class. J Biol Chem. 1990 May 25;265(15):8542–8549. [PubMed] [Google Scholar]
  35. Reinherz E. L., Schlossman S. F. The differentiation and function of human T lymphocytes. Cell. 1980 Apr;19(4):821–827. doi: 10.1016/0092-8674(80)90072-0. [DOI] [PubMed] [Google Scholar]
  36. Sayre P. H., Chang H. C., Hussey R. E., Brown N. R., Richardson N. E., Spagnoli G., Clayton L. K., Reinherz E. L. Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes. Proc Natl Acad Sci U S A. 1987 May;84(9):2941–2945. doi: 10.1073/pnas.84.9.2941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sayre P. H., Hussey R. E., Chang H. C., Ciardelli T. L., Reinherz E. L. Structural and binding analysis of a two domain extracellular CD2 molecule. J Exp Med. 1989 Mar 1;169(3):995–1009. doi: 10.1084/jem.169.3.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. 1987 Oct 29-Nov 4Nature. 329(6142):840–842. doi: 10.1038/329840a0. [DOI] [PubMed] [Google Scholar]
  39. Seed B., Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci U S A. 1987 May;84(10):3365–3369. doi: 10.1073/pnas.84.10.3365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sewell W. A., Palmer R. W., Spurr N. K., Sheer D., Brown M. H., Bell Y., Crumpton M. J. The human LFA-3 gene is located at the same chromosome band as the gene for its receptor CD2. Immunogenetics. 1988;28(4):278–282. doi: 10.1007/BF00345506. [DOI] [PubMed] [Google Scholar]
  41. Siliciano R. F., Pratt J. C., Schmidt R. E., Ritz J., Reinherz E. L. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 1985 Oct 3;317(6036):428–430. doi: 10.1038/317428a0. [DOI] [PubMed] [Google Scholar]
  42. Somoza C., Driscoll P. C., Cyster J. G., Williams A. F. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2. J Exp Med. 1993 Aug 1;178(2):549–558. doi: 10.1084/jem.178.2.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Staunton D. E., Fisher R. C., LeBeau M. M., Lawrence J. B., Barton D. E., Francke U., Dustin M., Thorley-Lawson D. A. Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23. J Exp Med. 1989 Mar 1;169(3):1087–1099. doi: 10.1084/jem.169.3.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Staunton D. E., Thorley-Lawson D. A. Molecular cloning of the lymphocyte activation marker Blast-1. EMBO J. 1987 Dec 1;6(12):3695–3701. doi: 10.1002/j.1460-2075.1987.tb02703.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tiefenthaler G., Dustin M. L., Springer T. A., Hünig T. Serologic cross-reactivity of T11 target structure and lymphocyte function-associated antigen 3. Evidence for structural homology of the sheep and human ligands of CD2. J Immunol. 1987 Oct 15;139(8):2696–2701. [PubMed] [Google Scholar]
  46. Wallner B. P., Frey A. Z., Tizard R., Mattaliano R. J., Hession C., Sanders M. E., Dustin M. L., Springer T. A. Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein. J Exp Med. 1987 Oct 1;166(4):923–932. doi: 10.1084/jem.166.4.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wang J. H., Yan Y. W., Garrett T. P., Liu J. H., Rodgers D. W., Garlick R. L., Tarr G. E., Husain Y., Reinherz E. L., Harrison S. C. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature. 1990 Nov 29;348(6300):411–418. doi: 10.1038/348411a0. [DOI] [PubMed] [Google Scholar]
  48. Williams A. F., Barclay A. N. The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol. 1988;6:381–405. doi: 10.1146/annurev.iy.06.040188.002121. [DOI] [PubMed] [Google Scholar]
  49. Withka J. M., Wyss D. F., Wagner G., Arulanandam A. R., Reinherz E. L., Recny M. A. Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2. Structure. 1993 Sep 15;1(1):69–81. doi: 10.1016/0969-2126(93)90009-6. [DOI] [PubMed] [Google Scholar]
  50. Wong Y. W., Williams A. F., Kingsmore S. F., Seldin M. F. Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3. J Exp Med. 1990 Jun 1;171(6):2115–2130. doi: 10.1084/jem.171.6.2115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wyss D. F., Withka J. M., Knoppers M. H., Sterne K. A., Recny M. A., Wagner G. 1H resonance assignments and secondary structure of the 13.6 kDa glycosylated adhesion domain of human CD2. Biochemistry. 1993 Oct 19;32(41):10995–11006. doi: 10.1021/bi00092a008. [DOI] [PubMed] [Google Scholar]
  52. Yang S. Y., Chouaib S., Dupont B. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. J Immunol. 1986 Aug 15;137(4):1097–1100. [PubMed] [Google Scholar]
  53. Yokoyama S., Staunton D., Fisher R., Amiot M., Fortin J. J., Thorley-Lawson D. A. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol. 1991 Apr 1;146(7):2192–2200. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES